BIOBLOCK MEDIHEX Trademark

Trademark Overview


On Friday, October 15, 2021, a trademark application was filed for BIOBLOCK MEDIHEX with the United States Patent and Trademark Office. The USPTO has given the BIOBLOCK MEDIHEX trademark a serial number of 79325378. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Monday, April 8, 2024. This trademark is owned by Aktsiaselts CHEMI-PHARM. The BIOBLOCK MEDIHEX trademark is filed in the Pharmaceutical Products category with the following description:

Antiallergic medicines; pharmaceutical preparations and substances, namely, cardiovascular pharmaceutical preparations; milk ferments for pharmaceutical purposes; antibacterial sprays; flaxseeds for pharmaceutical purposes and natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; anti-viral substances being antivirals; anti-viral agents being antivirals; antiviral prodrugs being antivirals; nasal sprays for medical purposes; medicated nasal spray preparations
bioblock medihex

General Information


Serial Number79325378
Word MarkBIOBLOCK MEDIHEX
Filing DateFriday, October 15, 2021
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateMonday, April 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized wording "BIOBLOCK" in green over a white background and above a blue rectangle containing the stylized wording "MEDIHEX" in white to the left of a stylized "M: in white inside of a white hexagon.
Goods and ServicesAntiallergic medicines; pharmaceutical preparations and substances, namely, cardiovascular pharmaceutical preparations; milk ferments for pharmaceutical purposes; antibacterial sprays; flaxseeds for pharmaceutical purposes and natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; anti-viral substances being antivirals; anti-viral agents being antivirals; antiviral prodrugs being antivirals; nasal sprays for medical purposes; medicated nasal spray preparations
Pseudo MarkBIO BLOCK MEDI HEX
Indication of Colors claimedThe color(s) green, white, and blue is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAktsiaselts CHEMI-PHARM
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressEE

Trademark Events


Event DateEvent Description
Monday, April 8, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, October 7, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, May 1, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, April 12, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 12, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, March 7, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, March 7, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, March 7, 2023SUSPENSION LETTER WRITTEN
Saturday, February 11, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 5, 2022REFUSAL PROCESSED BY IB
Monday, August 15, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, August 15, 2022REFUSAL PROCESSED BY MPU
Thursday, July 28, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 27, 2022NON-FINAL ACTION WRITTEN
Friday, July 22, 2022ASSIGNED TO EXAMINER
Friday, November 19, 2021APPLICATION FILING RECEIPT MAILED
Monday, November 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 11, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB